ALMR 最新10-Q变化
将 ALMR 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-08-11 与上一份 10-Q · 2026-05-08
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +26 | −11 | ~26 | 47 |
| 市场风险(第3项) | 文字有新增/删除 | 0 | 0 | ~1 | 0 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~1 | 3 |
| 法律诉讼 | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 风险因素 | 文字有新增/删除 | +79 | −71 | ~47 | 389 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-08-11
compensation-related costs and higher consulting costs associated with technology and product development. Compensation-related costs include a $0.6 million increase in stock-based compensation expense.
Our results of operations for each of the periods indicated are summarized in the table below:
Revenue was $55.5 million in the six months ended June 30, 2026 compared to $29.3 million in the six months ended June 30, 2025. Product revenue, which is comprised of instrument revenue and consumables revenue, increased by $23.4 million, or 110%, to $44.6 million in the six months ended June 30, 2…
Service and other revenue increased by $2.8 million, or 35%, to $10.9 million in the six months ended June 30, 2026, compared to $8.0 million in the six months ended June 30, 2025. The increase was primarily due to increased TAP services, including services to develop custom assays.
Cost of revenue was $23.3 million in the six months ended June 30, 2026 compared to $14.3 million in the six months ended June 30, 2025. Cost of product revenue increased by $7.8 million, or 66%, to $19.7 million in the six months ended June 30, 2026, compared to $11.9 million in the six months ende…
相对上期删除的文字 · 来源:10-Q · 2026-05-08
Comparison of the three months ended March 31, 2026 and 2025
personnel headcount, which resulted in higher compensation-related costs and higher consulting costs associated with technology and product development.
As of March 31, 2026, we had $64.6 million in unrestricted cash and cash equivalents, $4.9 million in restricted cash, and access to a total of up to $50.0 million of unused committed term loan facility and undrawn revolver balance with Silicon Valley Bank, a division of First Citizens Bank (“SVB”),…
Since inception, our principal sources of liquidity have been proceeds from the sale of our equity securities, revenue from sales of our products and services, and, to a lesser extent, borrowings from loan facilities. As of March 31, 2026, we had an accumulated deficit of $190.1 million, attributabl…
On July 11, 2024, we entered into a loan and security agreement with SVB which permitted us to draw term loan advances of up to an aggregate sum of $35.0 million under Tranche A and Tranche B. This amount remained undrawn until the agreement was amended in September 2025. On September 19, 2025, we e…
风险因素
相对上期新增的文字 · 来源:10-Q · 2026-08-11
We and/or our third-party manufacturing partner may be unable to consistently manufacture our products to the necessary specifications or in quantities necessary to meet demand at an acceptable cost or at an acceptable performance level.
qualifications. Our ability to increase our manufacturing capacity at our Fremont, California is complicated by the use of our validated equipment model that is not readily available from third-party manufacturer.
Additionally, we have not qualified secondary sources for all materials or components that we source through a single
specifications and instructions. If any of these issues occur, we may also incur significant costs, the attention of our key personnel could be diverted or other significant customer relations problems may arise.
expenses related to our facilities and real estate, including costs and/or disruptions related to tenant improvements;
相对上期删除的文字 · 来源:10-Q · 2026-05-08
We and/or our third-party manufacturing partner may be unable to consistently manufacture our products to the
necessary specifications or in quantities necessary to meet demand at an acceptable cost or at an acceptable performance level.
of our validated equipment model that is not readily available from third-party manufacturer.
Additionally, we have not qualified secondary sources for all materials or components that we source through a single supplier and we cannot assure investors that the qualification of a secondary supplier will prevent future supply issues.
key personnel could be diverted or other significant customer relations problems may arise.
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议